The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) constitutes a major health concern with the increasing incidence of obesity and diabetes in many Western countries, reaching a prevalence of up to 30% in the general population. Animal models have played a vital role in elucidating the pathophysiological mechanisms of NAFLD and continue to do so. A myriad of different models exists, each with its advantages and disadvantages. This review presents a brief overview of these models with a particular focus on the basic mechanisms and physical, biochemical and histological phenotype. Both nutritional and chemically induced, as well as genetic models are examined, including models combining different approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C., & Roudot-Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,341
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303816 · Cited by 1,001
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice†
Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S. C., & Bergheim, I. (2009) · Hepatology · doi:10.1002/hep.23122 · Cited by 562
Francque, S. M., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 556
Self-citationAnimal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Takahashi, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i19.2300 · Cited by 554
An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis
Matsumoto, M., Hada, N., Sakamaki, Y., Uno, A., Shiga, T., Tanaka, C., Ito, T., Katsume, A., & Sudoh, M. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12008 · Cited by 523
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin
Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., McClain, C. J., & Bischoff, S. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.035 · Cited by 522
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
Matsuzawa, N., Takamura, T., Kurita, S., Misu, H., Ota, T., Ando, H., Yokoyama, M., Honda, M., Zen, Y., Nakanuma, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21874 · Cited by 515
Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Wang, B., Chandrasekera, P., & Pippin, J. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140508121012 · Cited by 506
Charlton, M., Krishnan, A., Viker, K., Sanderson, S., Cazanave, S., McConico, A., Masuoko, H., & Gores, G. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00145.2011 · Cited by 444
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
Yasui, K., Hashimoto, E., Komorizono, Y., Koike, K., Arii, S., Imai, Y., Shima, T., Kanbara, Y., Saibara, T., Mori, T., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.01.023 · Cited by 420
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Haas, J. T., Francque, S., & Staels, B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105331 · Cited by 394
Self-citationTetri, L. H., Basaranoglu, M., Brunt, E. M., Yerian, L. M., & Neuschwander-Tetri, B. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90272.2008 · Cited by 378
Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances
Lau, J. K. C., Zhang, X., & Yu, J. (2017) · The Journal of Pathology · doi:10.1002/path.4829 · Cited by 373 · cited 3×
“The excess supply of free fatty acids, directly via intake and via increased lipolysis, brings about triglyceride accumulation in the liver [26].”
BackgroundRelationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots
Chusyd, D. E., Wang, D., Huffman, D. M., & Nagy, T. R. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00010 · Cited by 357
The Physiology of Obese-Hyperglycemic Mice [ob/ob Mice]
Lindström, P. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.117 · Cited by 356
Fujii, M., Shibazaki, Y., Wakamatsu, K., Honda, Y., Kawauchi, Y., Suzuki, K., Arumugam, S., Watanabe, K., Ichida, T., Asakura, H., et al. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0016-1 · Cited by 355
High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase
Ishimoto, T., Lanaspa, M. A., Rivard, C. J., Roncal-Jimenez, C. A., Orlicky, D. J., Cicerchi, C., McMahan, R. H., Abdelmalek, M. F., Rosen, H. R., Jackman, M. R., et al. (2013) · Hepatology · doi:10.1002/hep.26594 · Cited by 331
du Plessis, J., van Pelt, J., Korf, H., Mathieu, C., van der Schueren, B., Lannoo, M., Oyen, T., Topal, B., Fetter, G., Nayler, S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.044 · Cited by 325
Self-citationClapper, J. R., Hendricks, M. D., Gu, G., Wittmer, C., Dolman, C. S., Herich, J., Athanacio, J., Villescaz, C., Ghosh, S. S., Heilig, J. S., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2013 · Cited by 294
Synthetic low and high fat diets for the study of atherosclerosis in the mouse.
Nishina, P., Verstuyft, J., & Paigen, B. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42785-3 · Cited by 293
In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
Kanuri, G., & Bergheim, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140611963 · Cited by 290
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Chachay, V. S., Macdonald, G. A., Martin, J. H., Whitehead, J. P., O'Moore–Sullivan, T. M., Lee, P., Franklin, M., Klein, K., Taylor, P. J., Ferguson, M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.024 · Cited by 289
Trevaskis, J. L., Griffin, P. S., Wittmer, C., Neuschwander-Tetri, B. A., Brunt, E. M., Dolman, C. S., Erickson, M. R., Napora, J., Parkes, D. G., & Roth, J. D. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00476.2011 · Cited by 277
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Hansen, H. H., Feigh, M., Veidal, S. S., Rigbolt, K. T., Vrang, N., & Fosgerau, K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.007 · Cited by 270
KIRSCH, R., CLARKSON, V., SHEPHARD, E. G., MARAIS, D. A., JAFFER, M. A., WOODBURNE, V. E., KIRSCH, R. E., & HALL, P. D. L. M. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03198.x · Cited by 262
Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet
Ito, M., Suzuki, J., Tsujioka, S., Sasaki, M., Gomori, A., Shirakura, T., Hirose, H., Ito, M., Ishihara, A., Iwaasa, H., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00008.x · Cited by 253
Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo
Williams, K. H., Shackel, N. A., Gorrell, M. D., McLennan, S. V., & Twigg, S. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1009 · Cited by 233
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
Ibrahim, S. H., Hirsova, P., Malhi, H., & Gores, G. J. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3977-1 · Cited by 218
Kodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., De Minicis, S., Österreicher, C. H., Schnabl, B., Seki, E., & Brenner, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.045 · Cited by 195
Sellmann, C., Priebs, J., Landmann, M., Degen, C., Engstler, A. J., Jin, C. J., Gärttner, S., Spruss, A., Huber, O., & Bergheim, I. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.05.011 · Cited by 184
Nonalcoholic steatohepatitis: a search for factual animal models
Sanches, S. C. L., Ramalho, L. N. Z., Augusto, M. J., da Silva, D. M., & Ramalho, F. S. (2015) · BioMed Research International · doi:10.1155/2015/574832 · Cited by 174
Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis
Itoh, M., Suganami, T., Nakagawa, N., Tanaka, M., Yamamoto, Y., Kamei, Y., Terai, S., Sakaida, I., & Ogawa, Y. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.07.014 · Cited by 167
Itagaki, H., Shimizu, K., Morikawa, S., Ogawa, K., & Ezaki, T. (2013) · Europe PMC (PubMed Central) · Cited by 159
Trak-Smayra, V. E., Paradis, V., Massart, J., Nasser, S. M., Jebara, V. A., & Fromenty, B. (2011) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2011.00793.x · Cited by 155
Does Leptin Play A Role in The Pathogenesis of Human Nonalcoholic Steatohepatitis?
Chalasani, N., Crabb, D. W., Cummings, O. W., Kwo, P. Y., Asghar, A., Pandya, P., & Considine, R. V. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.08767.x · Cited by 151
Liver Fat in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Yki‐Järvinen, H. (2010) · Digestive Diseases · doi:10.1159/000282087 · Cited by 131
Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin
Domitrović, R., Jakovac, H., Tomac, J., & Šain, I. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.09.001 · Cited by 128
板垣, 裕. (2012) · Institutional Repositories DataBase (IRDB) · Cited by 124
Gauthier, M., Favier, R. J. M., & Lavoie, J.-M. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20051635 · Cited by 123
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
Kristiansen, M. N. B., Veidal, S. S., Rigbolt, K. T. G., Tølbøl, K. S., Roth, J. D., Jelsing, J., Vrang, N., & Feigh, M. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i16.673 · Cited by 123
Lo, L. W.-Y., McLennan, S. V., Williams, P. F., Bonner, J. G., Chowdhury, S., McCaughan, G. W., Gorrell, M. D., Yue, D. K., & Twigg, S. M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.039 · Cited by 117
Gandhi, C. R., Chaillet, J. R., Nalesnik, M. A., Kumar, S., Dangi, A., Demetris, A. J., Ferrell, R. E., Wu, T., Divanovic, S., Stankeiwicz, T., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.10.008 · Cited by 104
HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
De Minicis, S., Agostinelli, L., Rychlicki, C., Sorice, G. P., Saccomanno, S., Candelaresi, C., Giaccari, A., Trozzi, L., Pierantonelli, I., Mingarelli, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097136 · Cited by 97
Kubota, N., Kado, S., Mitsuyoshi, K. A. N. O., Masuoka, N., Nagata, Y., Kobayashi, T., Miyazaki, K., & Ishikawa, F. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12102 · Cited by 95
Optimized Mouse Models for Liver Fibrosis
Kim, Y. O., Popov, Y. V., & Schuppan, D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6786-5_19 · Cited by 84
Ezetimibe for the treatment of non‐alcoholic fatty liver disease: A meta‐analysis
Nakade, Y., Murotani, K., Inoue, T., Kobayashi, Y., Yamamoto, T., Ishii, N., Ohashi, T., Ito, K., Fukuzawa, Y., & Yoneda, M. (2017) · Hepatology Research · doi:10.1111/hepr.12887 · Cited by 83
Effects of High-Fructose Diets on Central Appetite Signaling and Cognitive Function
Lowette, K., Roosen, L., Tack, J. F., & Berghe, P. V. (2015) · Frontiers in Nutrition · doi:10.3389/fnut.2015.00005 · Cited by 70
Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
Vonghia, L., Michielsen, P. P., & Francque, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019867 · Cited by 68
Self-citationMamikutty, N., Thent, Z. C., & Suhaimi, F. H. (2015) · BioMed Research International · doi:10.1155/2015/895961 · Cited by 67
Crescenzo, R., Bianco, F., Coppola, P., Mazzoli, A., Tussellino, M., Carotenuto, R., Liverini, G., & Iossa, S. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.079632 · Cited by 66
Toriguchi, K., Hatano, E., Tanabe, K., Takemoto, K., Nakamura, K., Koyama, Y., Seo, S., Taura, K., & Üemoto, S. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12481 · Cited by 65
Nakamura, I., Zakharia, K., Banini, B. A., Mikhail, D. S., Kim, T. H., Yang, J. D., Moser, C. D., Shaleh, H. M., Thornburgh, S. R., Walters, I. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092273 · Cited by 63
An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present
Jacobs, A., Warda, A., Verbeek, J., Cassiman, D. M., & Spincemaille, P. (2016) · Current Protocols in Mouse Biology · doi:10.1002/cpmo.3 · Cited by 61
Tsochatzis, E. A., Manolakopoulos, S., Papatheodoridis, G., & Archimandritis, A. J. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802273058 · Cited by 60
Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models
Ishioka, M., Miura, K., Minami, S., Shimura, Y., & Ohnishi, H. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4393-x · Cited by 57
Ratziu, V., Bédossa, P., Francque, S., Larrey, D. G., Aithal, G. P., Serfaty, L., Voiculescu, M., Preoțescu, L., Nevens, F., de Lédinghen, V., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.040 · Cited by 55
Self-citationNASH animal models: Are we there yet?
Kohli, R., & Feldstein, A. E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.010 · Cited by 53
Koppe, S., Elias, M. S., Moseley, R. H., & Green, R. M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90543.2008 · Cited by 53
Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning?
Baran, B., & Akyüz, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14219 · Cited by 52
Kwanten, W. J., Vandewynckel, Y., Martinet, W., Winter, B. Y. D., Michielsen, P. P., Hoof, V. O. V., Driessen, A. L. C., Timmermans, J., Bédossa, P., Vlierberghe, H. V., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00418.2015 · Cited by 52
Self-citationHigh fat diets and pathology in the guinea pig. Atherosclerosis or liver damage?
Ye, P., Cheah, I. K.-M., & Halliwell, B. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.008 · Cited by 50
Liu, Q., Wang, C. Y., Liu, Z., ́s, X. B., He, Y., Chen, S. S., & Bai, X. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2013.877491 · Cited by 46
Wu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8641 · Cited by 42
CD4+RORγt++ and Tregs in a Mouse Model of Diet‐Induced Nonalcoholic Steatohepatitis
Vonghia, L., Ruyssers, N. E., Schrijvers, D. M., Pelckmans, P. A., Michielsen, P. P., Clerck, L. S. D., Ramon, A., Jirillo, E., Ebo, D. G., Winter, B. Y. D., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/239623 · Cited by 37
Self-citationNakae, D., Mizumoto, Y., Andoh, N., Tamura, K., Horiguchi, K., Endoh, T., Kobayashi, E., Tsujiuchi, T., Denda, A., Lombardi, B., et al. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300504 · Cited by 36
Intestinal Permeability in Non-alcoholic Fatty LIVER Disease: The Gut-liver Axis
Scarpellini, E., Lupo, M., Iegri, C., Gasbarrini, A., Santis, A. D., & Tack, J. F. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216104334 · Cited by 36
Côté, I., Sock, E. T. N., Levy, E. H., & Lavoie, J.-M. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0459-5 · Cited by 35
A rabbit model of pediatric nonalcoholic steatohepatitis: The role of adiponectin
Fu, J., Fang, Y., Liang, L., Wang, C., Hong, F., & Dong, G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.912 · Cited by 35
Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats
Longhi, R., Almeida, R. F., Machado, L. D. S., Duarte, M. M. M. F., de Souza, D. G., Machado, P. P., de Assis, A. M., Quincozes‐Santos, A., & Souza, D. O. (2016) · European Journal of Nutrition · doi:10.1007/s00394-015-1148-y · Cited by 35
Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?
Longato, L. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-14 · Cited by 32
Zhang, L., Wu, X., Liao, S., Li, Y., Zhang, Z., Chang, Q., Xiao, R., & Liang, B. (2016) · Biology Open · doi:10.1242/bio.020875 · Cited by 25
Thompson, K. J., Swan, R. Z., Walling, T. L., Iannitti, D. A., McKillop, I. H., & Sindram, D. (2013) · Surgical Endoscopy · doi:10.1007/s00464-013-2808-8 · Cited by 22
Cited by
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941
Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease
Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C., Chevet, E., & Bailly-Maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 944
Araújo, A. R., Rosso, N., Bedogni, G., Tiribelli, C., & Bellentani, S. (2018) · Liver International · doi:10.1111/liv.13643 · Cited by 401
Metadata
- Authors
- Van Herck, M., Vonghia, L., & Francque, S.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-09-27
- Volume
- 9
- Issue
- 10
- Pages
- 1072
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2757980641
- Cited by
- 392
- References
- 80
- FWCI
- 20.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.